Bolt Biotherapeutics Clinical Trials

If you are interested in participating in a clinical trial for one of our investigational medicines below, we encourage you to speak with your physician about the possibility of enrolling.

Program	Phase	Indication
BDC-1001	2	• Colorectal cancer • Endometrial cancer • Gastroesophageal cancer	Learn More at clinicaltrials.gov*
BDC-1001	2	• Metastatic breast cancer	Learn More at clinicaltrials.gov*

*You will be directed to a third-party website where you will be provided with additional information about Bolt Biotherapeutics’ clinical studies.

Expanded Access Policy

At this time, participation in clinical trials is the only way to gain access to our investigational medicines. Bolt Biotherapeutics will review and update its policy on offering patients Expanded Access from time to time as additional clinical data becomes available.